Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
Journal of Clinical & Laboratory Immunology|February 1, 1982
Recovery of lymphocyte function after radiation therapy for cancer in relationship to prognosisJ A Stratton, P E Fast, I WeintraubAnnals of Internal Medicine|October 15, 1994
NIH conference. HIV vaccine development: a progress reportD F Hoth, D P Bolognesi, L Corey, et al.Cancer Research|August 1, 1987
Role of thymidine in biochemical modulation: a reviewP J O'Dwyer, S A King, D F Hoth, et al.Statistics in Medicine|March 1, 1993
The use of external monitoring committees in clinical trials of the National Institute of Allergy and Infectious DiseasesS S Ellenberg, M W Myers, W C Blackwelder, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Methodology for the rational development of methotrexate analogs in the clinicB Leyland-Jones, P J O'Dwyer, D F Hoth, et al.Investigational New Drugs|January 1, 1987
5-MethyltetrahydrohomofolateP J O'Dwyer, B H Wagner, D F Hoth, et al.Annual Review of Public Health|January 1, 1995
Statistical issues in the design of HIV vaccine trialsC Schaper, T R Fleming, S G Self, et al.Statistics in Medicine|June 10, 1998
Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populationsI M Longini, K Sagatelian, W N Rida, et al.Cancer Research|November 1, 1985
Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosineJ O Liliemark, W Plunkett, D O DixonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizerK Clagett-Carr, G Sarosy, J Plowman, et al.Pageof 9